Literature DB >> 21877298

Cell death in the pathogenesis of immune-mediated diseases: the role of HMGB1 and DAMP-PAMP complexes.

D Pisetsky1.   

Abstract

Cell death is a ubiquitous process whose immunological consequences can influence the course of infectious, autoimmune and inflammatory diseases. While cell death has long been dichotomised in terms of apoptosis and necrosis, other forms of death can occur and they vary in their capacity to stimulate as well as inhibit inflammation. The pro-inflammatory activity of dead cells results from a wide variety of intracellular molecules that are released as cell permeability increases during death. These molecules have been termed as DAMPs (damage associated molecular patterns) or alarmins. Among these DAMPs, HMGB1, a non-histone nuclear protein, serves as the prototype. Although HMGB1 was originally thought to act alone as a cytokine, recent studies suggest that its immunological effects result from complexes of HMGB1 with either other DAMPs or with PAMPs (pathogen associated molecular patterns). Studies on the role of HMGB1 in pathogenesis suggest that the formation of extracellular complexes is an important mechanism for generating pro-inflammatory signals during cell death and therefore could be a potential target of new therapy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21877298      PMCID: PMC3724463          DOI: 10.4414/smw.2011.13256

Source DB:  PubMed          Journal:  Swiss Med Wkly        ISSN: 0036-7672            Impact factor:   2.193


  48 in total

Review 1.  How dying cells alert the immune system to danger.

Authors:  Hajime Kono; Kenneth L Rock
Journal:  Nat Rev Immunol       Date:  2008-03-14       Impact factor: 53.106

2.  Post-translational methylation of high mobility group box 1 (HMGB1) causes its cytoplasmic localization in neutrophils.

Authors:  Ichiaki Ito; Jutarou Fukazawa; Michiteru Yoshida
Journal:  J Biol Chem       Date:  2007-04-02       Impact factor: 5.157

3.  Induction of immunological tolerance by apoptotic cells requires caspase-dependent oxidation of high-mobility group box-1 protein.

Authors:  Hirotaka Kazama; Jean-Ehrland Ricci; John M Herndon; George Hoppe; Douglas R Green; Thomas A Ferguson
Journal:  Immunity       Date:  2008-07-18       Impact factor: 31.745

4.  HMGB1 develops enhanced proinflammatory activity by binding to cytokines.

Authors:  Yonggang Sha; Jaroslaw Zmijewski; Zhiwei Xu; Edward Abraham
Journal:  J Immunol       Date:  2008-02-15       Impact factor: 5.422

5.  Novel cell death program leads to neutrophil extracellular traps.

Authors:  Tobias A Fuchs; Ulrike Abed; Christian Goosmann; Robert Hurwitz; Ilka Schulze; Volker Wahn; Yvette Weinrauch; Volker Brinkmann; Arturo Zychlinsky
Journal:  J Cell Biol       Date:  2007-01-08       Impact factor: 10.539

Review 6.  High-mobility group box protein 1 (HMGB1): an alarmin mediating the pathogenesis of rheumatic disease.

Authors:  David S Pisetsky; Helena Erlandsson-Harris; Ulf Andersson
Journal:  Arthritis Res Ther       Date:  2008-06-30       Impact factor: 5.156

7.  Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009.

Authors:  G Kroemer; L Galluzzi; P Vandenabeele; J Abrams; E S Alnemri; E H Baehrecke; M V Blagosklonny; W S El-Deiry; P Golstein; D R Green; M Hengartner; R A Knight; S Kumar; S A Lipton; W Malorni; G Nuñez; M E Peter; J Tschopp; J Yuan; M Piacentini; B Zhivotovsky; G Melino
Journal:  Cell Death Differ       Date:  2008-10-10       Impact factor: 15.828

8.  The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel 'alarmin'?

Authors:  Christine Moussion; Nathalie Ortega; Jean-Philippe Girard
Journal:  PLoS One       Date:  2008-10-06       Impact factor: 3.240

9.  Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE.

Authors:  Vilma Urbonaviciute; Barbara G Fürnrohr; Silke Meister; Luis Munoz; Petra Heyder; Francesco De Marchis; Marco E Bianchi; Carsten Kirschning; Hermann Wagner; Angelo A Manfredi; Joachim R Kalden; Georg Schett; Patrizia Rovere-Querini; Martin Herrmann; Reinhard E Voll
Journal:  J Exp Med       Date:  2008-12-08       Impact factor: 14.307

Review 10.  Secondary necrosis in multicellular animals: an outcome of apoptosis with pathogenic implications.

Authors:  Manuel T Silva; Ana do Vale; Nuno M N dos Santos
Journal:  Apoptosis       Date:  2008-03-06       Impact factor: 4.677

View more
  28 in total

Review 1.  Microparticles as mediators and biomarkers of rheumatic disease.

Authors:  David S Pisetsky; Anirudh J Ullal; Julie Gauley; Tony C Ning
Journal:  Rheumatology (Oxford)       Date:  2012-03-07       Impact factor: 7.580

2.  Proteomic mapping of proteins released during necrosis and apoptosis from cultured neonatal cardiac myocytes.

Authors:  Kurt D Marshall; Michelle A Edwards; Maike Krenz; J Wade Davis; Christopher P Baines
Journal:  Am J Physiol Cell Physiol       Date:  2014-01-08       Impact factor: 4.249

3.  Serum-stabilized naked caspase-3 siRNA protects autotransplant kidneys in a porcine model.

Authors:  Cheng Yang; Tian Zhao; Zitong Zhao; Yichen Jia; Long Li; Yufang Zhang; Mangen Song; Ruiming Rong; Ming Xu; Michael L Nicholson; Tongyu Zhu; Bin Yang
Journal:  Mol Ther       Date:  2014-06-16       Impact factor: 11.454

Review 4.  The crosstalk of telomere dysfunction and inflammation through cell-free TERRA containing exosomes.

Authors:  Zhuo Wang; Paul M Lieberman
Journal:  RNA Biol       Date:  2016-06-28       Impact factor: 4.652

Review 5.  DAMPs activating innate and adaptive immune responses in COPD.

Authors:  S D Pouwels; I H Heijink; N H T ten Hacken; P Vandenabeele; D V Krysko; M C Nawijn; A J M van Oosterhout
Journal:  Mucosal Immunol       Date:  2013-10-23       Impact factor: 7.313

Review 6.  The origin and properties of extracellular DNA: from PAMP to DAMP.

Authors:  David S Pisetsky
Journal:  Clin Immunol       Date:  2012-05-03       Impact factor: 3.969

Review 7.  The translocation of nuclear molecules during inflammation and cell death.

Authors:  David S Pisetsky
Journal:  Antioxid Redox Signal       Date:  2013-03-20       Impact factor: 8.401

Review 8.  HMGB1 in health and disease.

Authors:  Rui Kang; Ruochan Chen; Qiuhong Zhang; Wen Hou; Sha Wu; Lizhi Cao; Jin Huang; Yan Yu; Xue-Gong Fan; Zhengwen Yan; Xiaofang Sun; Haichao Wang; Qingde Wang; Allan Tsung; Timothy R Billiar; Herbert J Zeh; Michael T Lotze; Daolin Tang
Journal:  Mol Aspects Med       Date:  2014-07-08

9.  High Mobility Group Box-1 Drives Fibrosis Progression Signaling via the Receptor for Advanced Glycation End Products in Mice.

Authors:  Xiaodong Ge; Elena Arriazu; Fernando Magdaleno; Daniel J Antoine; Rouchelle Dela Cruz; Neil Theise; Natalia Nieto
Journal:  Hepatology       Date:  2018-11-13       Impact factor: 17.425

Review 10.  The complex role of DNA, histones and HMGB1 in the pathogenesis of SLE.

Authors:  David S Pisetsky
Journal:  Autoimmunity       Date:  2014-06-11       Impact factor: 2.815

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.